

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of B cell proliferation (GO:0030889) | 9.53152450 |
| 2 | B cell receptor signaling pathway (GO:0050853) | 8.03601788 |
| 3 | positive regulation of respiratory burst (GO:0060267) | 7.96853524 |
| 4 | gonadal mesoderm development (GO:0007506) | 7.86402333 |
| 5 | complement activation, classical pathway (GO:0006958) | 7.52261598 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.10715669 |
| 7 | glomerular filtration (GO:0003094) | 7.06916418 |
| 8 | regulation of regulatory T cell differentiation (GO:0045589) | 6.86928728 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.58092895 |
| 10 | renal filtration (GO:0097205) | 6.36573945 |
| 11 | regulation of B cell proliferation (GO:0030888) | 5.99190044 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.87588260 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.87588260 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.82283070 |
| 15 | complement activation (GO:0006956) | 5.79334380 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 5.67009423 |
| 17 | regulation of respiratory burst (GO:0060263) | 5.35293420 |
| 18 | regulation of B cell differentiation (GO:0045577) | 5.32555145 |
| 19 | B cell proliferation (GO:0042100) | 5.29796472 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.06867526 |
| 21 | negative regulation of B cell activation (GO:0050869) | 5.00422464 |
| 22 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.80968860 |
| 23 | antibacterial humoral response (GO:0019731) | 4.67950738 |
| 24 | antimicrobial humoral response (GO:0019730) | 4.66161928 |
| 25 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 4.66051537 |
| 26 | Fc-gamma receptor signaling pathway (GO:0038094) | 4.66051537 |
| 27 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 4.66051537 |
| 28 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.64410426 |
| 29 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 4.63031957 |
| 30 | negative regulation of cell aging (GO:0090344) | 4.59456539 |
| 31 | regulation of chronic inflammatory response (GO:0002676) | 4.55595259 |
| 32 | defense response to protozoan (GO:0042832) | 4.53916871 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.50259443 |
| 34 | negative regulation of glucose import (GO:0046325) | 4.36227955 |
| 35 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.27942628 |
| 36 | regulation of B cell activation (GO:0050864) | 4.21888047 |
| 37 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.16892632 |
| 38 | humoral immune response (GO:0006959) | 4.16812675 |
| 39 | serine transport (GO:0032329) | 4.11705724 |
| 40 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.11424645 |
| 41 | cellular response to zinc ion (GO:0071294) | 4.06947345 |
| 42 | L-serine transport (GO:0015825) | 4.05881814 |
| 43 | negative regulation of cell killing (GO:0031342) | 4.04599179 |
| 44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.04599179 |
| 45 | retina homeostasis (GO:0001895) | 4.03272226 |
| 46 | leukocyte aggregation (GO:0070486) | 4.03115326 |
| 47 | regulation of cellular extravasation (GO:0002691) | 4.02302078 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 4.00738321 |
| 49 | response to protozoan (GO:0001562) | 3.98427787 |
| 50 | regulation of gamma-delta T cell activation (GO:0046643) | 3.94800993 |
| 51 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.88631454 |
| 52 | regulation of B cell apoptotic process (GO:0002902) | 3.87855547 |
| 53 | positive regulation of immunoglobulin production (GO:0002639) | 3.87304939 |
| 54 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.85567964 |
| 55 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.77248186 |
| 56 | regulation of immunoglobulin production (GO:0002637) | 3.73982049 |
| 57 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.72039787 |
| 58 | mature B cell differentiation (GO:0002335) | 3.67337765 |
| 59 | protein activation cascade (GO:0072376) | 3.64221072 |
| 60 | T cell lineage commitment (GO:0002360) | 3.63899477 |
| 61 | hepatocyte apoptotic process (GO:0097284) | 3.60966201 |
| 62 | negative regulation of humoral immune response (GO:0002921) | 3.60252805 |
| 63 | type I interferon signaling pathway (GO:0060337) | 3.57731532 |
| 64 | cellular response to type I interferon (GO:0071357) | 3.57731532 |
| 65 | germinal center formation (GO:0002467) | 3.57442913 |
| 66 | positive thymic T cell selection (GO:0045059) | 3.56765783 |
| 67 | detection of bacterium (GO:0016045) | 3.55922671 |
| 68 | negative regulation of glucose transport (GO:0010829) | 3.55868286 |
| 69 | signal peptide processing (GO:0006465) | 3.55165420 |
| 70 | detection of other organism (GO:0098543) | 3.54603906 |
| 71 | response to type I interferon (GO:0034340) | 3.54464042 |
| 72 | negative thymic T cell selection (GO:0045060) | 3.50125893 |
| 73 | B cell activation (GO:0042113) | 3.46601120 |
| 74 | positive regulation of Rap GTPase activity (GO:0032854) | 3.45478411 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 3.41070679 |
| 76 | regulation of antigen processing and presentation (GO:0002577) | 3.38560210 |
| 77 | negative T cell selection (GO:0043383) | 3.31606866 |
| 78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.27380763 |
| 79 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.27004694 |
| 80 | T cell selection (GO:0045058) | 3.25129715 |
| 81 | mast cell activation (GO:0045576) | 3.25078609 |
| 82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.24998515 |
| 83 | B cell differentiation (GO:0030183) | 3.23726813 |
| 84 | negative regulation of mononuclear cell proliferation (GO:0032945) | 3.21968669 |
| 85 | negative regulation of lymphocyte proliferation (GO:0050672) | 3.21968669 |
| 86 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.17711722 |
| 87 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.16746052 |
| 88 | regulation of isotype switching (GO:0045191) | 3.15768522 |
| 89 | positive regulation of antigen processing and presentation (GO:0002579) | 3.15205388 |
| 90 | negative regulation of phagocytosis (GO:0050765) | 3.13556522 |
| 91 | chronic inflammatory response (GO:0002544) | 3.13434102 |
| 92 | positive regulation of B cell proliferation (GO:0030890) | 3.13370296 |
| 93 | response to interleukin-15 (GO:0070672) | 3.11937454 |
| 94 | tolerance induction (GO:0002507) | 3.11785570 |
| 95 | cellular response to interferon-gamma (GO:0071346) | 3.06792775 |
| 96 | B cell mediated immunity (GO:0019724) | 3.05736051 |
| 97 | negative regulation of myotube differentiation (GO:0010832) | 3.04957159 |
| 98 | negative regulation of leukocyte proliferation (GO:0070664) | 3.03368930 |
| 99 | positive regulation of B cell activation (GO:0050871) | 3.02885299 |
| 100 | neutrophil activation involved in immune response (GO:0002283) | 3.02237323 |
| 101 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.01973074 |
| 102 | lymphocyte proliferation (GO:0046651) | 3.01543470 |
| 103 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.01205492 |
| 104 | B cell homeostasis (GO:0001782) | 3.00535560 |
| 105 | mononuclear cell proliferation (GO:0032943) | 3.00000231 |
| 106 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.98410394 |
| 107 | myeloid dendritic cell differentiation (GO:0043011) | 2.98351058 |
| 108 | negative regulation of complement activation (GO:0045916) | 2.96765404 |
| 109 | lymphocyte costimulation (GO:0031294) | 2.96411622 |
| 110 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.96113773 |
| 111 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.95078949 |
| 112 | immune response-activating signal transduction (GO:0002757) | 2.91680143 |
| 113 | respiratory burst (GO:0045730) | 2.91022595 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 2.90994162 |
| 115 | response to interferon-gamma (GO:0034341) | 2.90459189 |
| 116 | thymic T cell selection (GO:0045061) | 2.90019183 |
| 117 | activation of immune response (GO:0002253) | 2.89393438 |
| 118 | response to inactivity (GO:0014854) | 2.87858420 |
| 119 | cellular response to interleukin-15 (GO:0071350) | 2.87262152 |
| 120 | dendritic cell chemotaxis (GO:0002407) | 2.87010264 |
| 121 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.86627863 |
| 122 | nucleoside transmembrane transport (GO:1901642) | 2.85989236 |
| 123 | regulation of Rap GTPase activity (GO:0032317) | 2.85832028 |
| 124 | surfactant homeostasis (GO:0043129) | 2.85523316 |
| 125 | mature B cell differentiation involved in immune response (GO:0002313) | 2.85318253 |
| 126 | hypotonic response (GO:0006971) | 2.85282717 |
| 127 | NIK/NF-kappaB signaling (GO:0038061) | 2.84346711 |
| 128 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84203004 |
| 129 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.82819285 |
| 130 | T cell costimulation (GO:0031295) | 2.81639847 |
| 131 | production of molecular mediator of immune response (GO:0002440) | 2.81341583 |
| 132 | regulation of T cell tolerance induction (GO:0002664) | 2.77912058 |
| 133 | protein-chromophore linkage (GO:0018298) | 2.77399901 |
| 134 | detection of external biotic stimulus (GO:0098581) | 2.76776108 |
| 135 | myeloid dendritic cell activation (GO:0001773) | 2.71632491 |
| 136 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.65175714 |
| 137 | regulation of integrin activation (GO:0033623) | 2.63717929 |
| 138 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62154479 |
| 139 | modulation by symbiont of host defense response (GO:0052031) | 2.62154479 |
| 140 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62154479 |
| 141 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62154479 |
| 142 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62154479 |
| 143 | modulation by symbiont of host immune response (GO:0052553) | 2.62154479 |
| 144 | COPI coating of Golgi vesicle (GO:0048205) | 2.62099975 |
| 145 | Golgi transport vesicle coating (GO:0048200) | 2.62099975 |
| 146 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.60623250 |
| 147 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.60458738 |
| 148 | interferon-gamma secretion (GO:0072643) | 2.55932647 |
| 149 | regulation of tolerance induction (GO:0002643) | 2.54445641 |
| 150 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.54334947 |
| 151 | peptide catabolic process (GO:0043171) | 2.52997678 |
| 152 | T-helper 1 type immune response (GO:0042088) | 2.52352992 |
| 153 | negative regulation of bone resorption (GO:0045779) | 2.51330465 |
| 154 | eosinophil chemotaxis (GO:0048245) | 2.50448893 |
| 155 | dendritic cell migration (GO:0036336) | 2.50184442 |
| 156 | angiotensin maturation (GO:0002003) | 2.46423609 |
| 157 | regulation of macrophage chemotaxis (GO:0010758) | 2.42592001 |
| 158 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 2.40696005 |
| 159 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.39536538 |
| 160 | defense response to Gram-negative bacterium (GO:0050829) | 2.38622449 |
| 161 | macrophage activation involved in immune response (GO:0002281) | 2.37098046 |
| 162 | virion attachment to host cell (GO:0019062) | 2.37078612 |
| 163 | adhesion of symbiont to host cell (GO:0044650) | 2.37078612 |
| 164 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.36220144 |
| 165 | cellular extravasation (GO:0045123) | 2.35687104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.84753980 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.58400932 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.31007892 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.88888468 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.84474289 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.57820901 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.96373647 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.83290831 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.66282020 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.63644856 |
| 11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.30768902 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28977282 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.27444349 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.24668010 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.12327342 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.96229304 |
| 17 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.91123057 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.84108381 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.78785395 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.75472297 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.70298734 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.58086948 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.56435690 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.54777308 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.24542988 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19935717 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.19196515 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18786310 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12871901 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10883964 |
| 31 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.10056791 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.04876857 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98061608 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.97155035 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96916535 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.93749234 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87002590 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85572269 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.80522033 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.78706925 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76675959 |
| 42 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.75051557 |
| 43 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.73887221 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.72593881 |
| 45 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.69961737 |
| 46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.69083406 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67412676 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.63143226 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59054824 |
| 50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59029876 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.56898901 |
| 52 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52745115 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51390172 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49725953 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47586243 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.45574739 |
| 57 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.41526942 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41489095 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.40168064 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40026332 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39745551 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36781944 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34415416 |
| 64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33455979 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31143457 |
| 66 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28855088 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27294649 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26010210 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25051769 |
| 70 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24939255 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24303555 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24182745 |
| 73 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22356535 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.20841140 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19715985 |
| 76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19038073 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18951470 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17230850 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17222683 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16591014 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16004606 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12448537 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11870861 |
| 84 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07571492 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06456563 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03567802 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03075522 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02733365 |
| 89 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01755562 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01747638 |
| 91 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99417962 |
| 92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98542603 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98301117 |
| 94 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98225205 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97931926 |
| 96 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96570058 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96305764 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95812107 |
| 99 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.94201327 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93370276 |
| 101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92905202 |
| 102 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92517941 |
| 103 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.92477229 |
| 104 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92005803 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91948712 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91731613 |
| 107 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90484061 |
| 108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89479252 |
| 109 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89410051 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89403136 |
| 111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89108128 |
| 112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88369059 |
| 113 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87483288 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87202668 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86576892 |
| 116 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85637299 |
| 117 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85069332 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84859153 |
| 119 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84801482 |
| 120 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.83718630 |
| 121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.79628293 |
| 122 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76813518 |
| 123 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76729783 |
| 124 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.75018551 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74027001 |
| 126 | GATA3_26560356_Chip-Seq_TH1_Human | 0.71706453 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71616402 |
| 128 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71544299 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.71111810 |
| 130 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.70064125 |
| 131 | P300_27268052_Chip-Seq_Bcells_Human | 0.70039288 |
| 132 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.69850790 |
| 133 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.68782312 |
| 134 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.67854891 |
| 135 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66759956 |
| 136 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66675810 |
| 137 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66124032 |
| 138 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.66066603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.95370425 |
| 2 | MP0001835_abnormal_antigen_presentation | 5.06432167 |
| 3 | MP0001800_abnormal_humoral_immune | 4.31783408 |
| 4 | MP0001790_abnormal_immune_system | 4.30496857 |
| 5 | MP0005387_immune_system_phenotype | 4.30496857 |
| 6 | MP0003300_gastrointestinal_ulcer | 3.66694014 |
| 7 | MP0005671_abnormal_response_to | 3.62003105 |
| 8 | MP0002452_abnormal_antigen_presenting | 3.27461267 |
| 9 | MP0001873_stomach_inflammation | 2.97138847 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.93435134 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.89827970 |
| 12 | MP0002723_abnormal_immune_serum | 2.80149779 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.79998731 |
| 14 | MP0001819_abnormal_immune_cell | 2.73576157 |
| 15 | MP0002398_abnormal_bone_marrow | 2.70650959 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.49294634 |
| 17 | MP0000716_abnormal_immune_system | 2.46155316 |
| 18 | MP0000689_abnormal_spleen_morphology | 2.37130690 |
| 19 | MP0000685_abnormal_immune_system | 2.35721664 |
| 20 | MP0005025_abnormal_response_to | 2.32083946 |
| 21 | MP0001853_heart_inflammation | 2.25595400 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.19437961 |
| 23 | MP0005275_abnormal_skin_tensile | 2.10267366 |
| 24 | MP0009785_altered_susceptibility_to | 2.09684634 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 2.06457241 |
| 26 | MP0002722_abnormal_immune_system | 2.05848509 |
| 27 | MP0003436_decreased_susceptibility_to | 2.04990248 |
| 28 | MP0002429_abnormal_blood_cell | 1.98315822 |
| 29 | MP0004782_abnormal_surfactant_physiolog | 1.88674368 |
| 30 | MP0002419_abnormal_innate_immunity | 1.87907271 |
| 31 | MP0005310_abnormal_salivary_gland | 1.83302171 |
| 32 | MP0002933_joint_inflammation | 1.83245075 |
| 33 | MP0001663_abnormal_digestive_system | 1.80153182 |
| 34 | MP0000490_abnormal_crypts_of | 1.78963145 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.78889445 |
| 36 | MP0006054_spinal_hemorrhage | 1.73139670 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.72430306 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.71424339 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.69985994 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.64829782 |
| 41 | MP0002405_respiratory_system_inflammati | 1.62723688 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.54458727 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.47165074 |
| 44 | MP0005503_abnormal_tendon_morphology | 1.44566141 |
| 45 | MP0004947_skin_inflammation | 1.43919117 |
| 46 | MP0000343_altered_response_to | 1.34156377 |
| 47 | MP0003693_abnormal_embryo_hatching | 1.32325158 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.29920083 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.29802428 |
| 50 | MP0008004_abnormal_stomach_pH | 1.28831145 |
| 51 | MP0001879_abnormal_lymphatic_vessel | 1.27827536 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.27374895 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.27081648 |
| 54 | MP0004858_abnormal_nervous_system | 1.27026639 |
| 55 | MP0010094_abnormal_chromosome_stability | 1.26509384 |
| 56 | MP0006082_CNS_inflammation | 1.26156060 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.24153088 |
| 58 | MP0003279_aneurysm | 1.22485389 |
| 59 | MP0005381_digestive/alimentary_phenotyp | 1.21100372 |
| 60 | MP0003045_fibrosis | 1.16302637 |
| 61 | MP0003866_abnormal_defecation | 1.14548930 |
| 62 | MP0002019_abnormal_tumor_incidence | 1.13528059 |
| 63 | MP0000604_amyloidosis | 1.10672380 |
| 64 | MP0001851_eye_inflammation | 1.09664883 |
| 65 | MP0005390_skeleton_phenotype | 1.09396554 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.06260211 |
| 67 | MP0009840_abnormal_foam_cell | 1.05986821 |
| 68 | MP0005164_abnormal_response_to | 1.05097587 |
| 69 | MP0001919_abnormal_reproductive_system | 1.02131501 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.00544152 |
| 71 | MP0002006_tumorigenesis | 0.98581955 |
| 72 | MP0003828_pulmonary_edema | 0.98025765 |
| 73 | MP0002928_abnormal_bile_duct | 0.97423192 |
| 74 | MP0005464_abnormal_platelet_physiology | 0.96409594 |
| 75 | MP0002796_impaired_skin_barrier | 0.96296278 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 0.93204564 |
| 77 | MP0001545_abnormal_hematopoietic_system | 0.93204564 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.91936686 |
| 79 | MP0008469_abnormal_protein_level | 0.89989541 |
| 80 | MP0004510_myositis | 0.89942172 |
| 81 | MP0001542_abnormal_bone_strength | 0.89603928 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.87983738 |
| 83 | MP0008057_abnormal_DNA_replication | 0.87549285 |
| 84 | MP0005058_abnormal_lysosome_morphology | 0.86636729 |
| 85 | MP0003329_amyloid_beta_deposits | 0.85323043 |
| 86 | MP0009278_abnormal_bone_marrow | 0.83544790 |
| 87 | MP0002133_abnormal_respiratory_system | 0.82728650 |
| 88 | MP0005388_respiratory_system_phenotype | 0.82728650 |
| 89 | MP0003868_abnormal_feces_composition | 0.80274406 |
| 90 | MP0005165_increased_susceptibility_to | 0.78829487 |
| 91 | MP0001666_abnormal_nutrient_absorption | 0.77256997 |
| 92 | MP0004264_abnormal_extraembryonic_tissu | 0.76881928 |
| 93 | MP0003077_abnormal_cell_cycle | 0.76236601 |
| 94 | MP0001664_abnormal_digestion | 0.73299451 |
| 95 | MP0001958_emphysema | 0.72546931 |
| 96 | MP0005451_abnormal_body_composition | 0.72059920 |
| 97 | MP0000249_abnormal_blood_vessel | 0.69545813 |
| 98 | MP0009764_decreased_sensitivity_to | 0.69510989 |
| 99 | MP0005085_abnormal_gallbladder_physiolo | 0.68625467 |
| 100 | MP0001216_abnormal_epidermal_layer | 0.68351320 |
| 101 | MP0002060_abnormal_skin_morphology | 0.68240713 |
| 102 | MP0000477_abnormal_intestine_morphology | 0.67555348 |
| 103 | MP0002139_abnormal_hepatobiliary_system | 0.67139399 |
| 104 | MP0000681_abnormal_thyroid_gland | 0.67136761 |
| 105 | MP0003091_abnormal_cell_migration | 0.66359953 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.64886367 |
| 107 | MP0003724_increased_susceptibility_to | 0.64470252 |
| 108 | MP0000609_abnormal_liver_physiology | 0.62309132 |
| 109 | MP0008874_decreased_physiological_sensi | 0.62095314 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.61359439 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.60734633 |
| 112 | MP0000003_abnormal_adipose_tissue | 0.60486920 |
| 113 | MP0003111_abnormal_nucleus_morphology | 0.59724881 |
| 114 | MP0009931_abnormal_skin_appearance | 0.59051644 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.58511807 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.57964549 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.57632904 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57031572 |
| 119 | MP0008873_increased_physiological_sensi | 0.56651743 |
| 120 | MP0005621_abnormal_cell_physiology | 0.54899741 |
| 121 | MP0003448_altered_tumor_morphology | 0.54037791 |
| 122 | MP0009763_increased_sensitivity_to | 0.53650124 |
| 123 | MP0005023_abnormal_wound_healing | 0.53395928 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.52778757 |
| 125 | MP0004957_abnormal_blastocyst_morpholog | 0.52606835 |
| 126 | MP0005389_reproductive_system_phenotype | 0.52463562 |
| 127 | MP0000598_abnormal_liver_morphology | 0.52129870 |
| 128 | MP0000858_altered_metastatic_potential | 0.51929418 |
| 129 | MP0003075_altered_response_to | 0.51851238 |
| 130 | MP0002083_premature_death | 0.51457088 |
| 131 | MP0005408_hypopigmentation | 0.48904944 |
| 132 | MP0000372_irregular_coat_pigmentation | 0.48284688 |
| 133 | MP0003795_abnormal_bone_structure | 0.43569463 |
| 134 | MP0002998_abnormal_bone_remodeling | 0.40704235 |
| 135 | MP0001191_abnormal_skin_condition | 0.40275200 |
| 136 | MP0005166_decreased_susceptibility_to | 0.38245010 |
| 137 | MP0000313_abnormal_cell_death | 0.37004488 |
| 138 | MP0010352_gastrointestinal_tract_polyps | 0.35530540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of B cell number (HP:0010975) | 8.86720478 |
| 2 | B lymphocytopenia (HP:0010976) | 8.86720478 |
| 3 | Agammaglobulinemia (HP:0004432) | 7.86685741 |
| 4 | Prostate neoplasm (HP:0100787) | 6.74219809 |
| 5 | Recurrent bronchitis (HP:0002837) | 6.35047530 |
| 6 | Cellulitis (HP:0100658) | 5.93573355 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 5.58670973 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.53266136 |
| 9 | Meningitis (HP:0001287) | 5.41456602 |
| 10 | Recurrent sinusitis (HP:0011108) | 5.31510994 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 5.30733414 |
| 12 | Recurrent viral infections (HP:0004429) | 5.25739151 |
| 13 | Verrucae (HP:0200043) | 5.12097532 |
| 14 | Papilloma (HP:0012740) | 5.12097532 |
| 15 | Thyroiditis (HP:0100646) | 5.03534282 |
| 16 | Hypoplasia of the thymus (HP:0000778) | 4.80386329 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 4.70494731 |
| 18 | Colitis (HP:0002583) | 4.55823489 |
| 19 | Severe combined immunodeficiency (HP:0004430) | 4.25199670 |
| 20 | IgM deficiency (HP:0002850) | 4.23530406 |
| 21 | Pulmonary infiltrates (HP:0002113) | 3.90922907 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 3.86141002 |
| 23 | Optic neuritis (HP:0100653) | 3.86141002 |
| 24 | Vasculitis (HP:0002633) | 3.85086591 |
| 25 | Inflammation of the large intestine (HP:0002037) | 3.77091984 |
| 26 | Combined immunodeficiency (HP:0005387) | 3.72536947 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.71100321 |
| 28 | Obstructive lung disease (HP:0006536) | 3.71100321 |
| 29 | Recurrent pneumonia (HP:0006532) | 3.68995898 |
| 30 | Myositis (HP:0100614) | 3.65972021 |
| 31 | Bronchitis (HP:0012387) | 3.63845793 |
| 32 | Sepsis (HP:0100806) | 3.62209146 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 3.62098419 |
| 34 | Abnormality of complement system (HP:0005339) | 3.60317462 |
| 35 | Malnutrition (HP:0004395) | 3.59196681 |
| 36 | T lymphocytopenia (HP:0005403) | 3.38050739 |
| 37 | Glomerulonephritis (HP:0000099) | 3.36861962 |
| 38 | Increased IgE level (HP:0003212) | 3.36395169 |
| 39 | Complement deficiency (HP:0004431) | 3.36128782 |
| 40 | Osteomyelitis (HP:0002754) | 3.34422754 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 3.34115460 |
| 42 | IgG deficiency (HP:0004315) | 3.33080906 |
| 43 | Orchitis (HP:0100796) | 3.28070006 |
| 44 | Spontaneous hematomas (HP:0007420) | 3.27851741 |
| 45 | Premature loss of primary teeth (HP:0006323) | 3.27725066 |
| 46 | Restrictive lung disease (HP:0002091) | 3.23641919 |
| 47 | Abnormality of T cell number (HP:0011839) | 3.21389893 |
| 48 | Recurrent fungal infections (HP:0002841) | 3.20421526 |
| 49 | IgA deficiency (HP:0002720) | 3.18926301 |
| 50 | Chronic sinusitis (HP:0011109) | 3.18850509 |
| 51 | Recurrent lower respiratory tract infections (HP:0002783) | 3.17227857 |
| 52 | Gangrene (HP:0100758) | 3.14334564 |
| 53 | Abnormality of the prostate (HP:0008775) | 3.08134250 |
| 54 | Skin rash (HP:0000988) | 3.02305349 |
| 55 | Lymphopenia (HP:0001888) | 2.97319736 |
| 56 | Recurrent otitis media (HP:0000403) | 2.96195915 |
| 57 | Abnormality of T cells (HP:0002843) | 2.95712263 |
| 58 | Urticaria (HP:0001025) | 2.89036250 |
| 59 | Small epiphyses (HP:0010585) | 2.86034805 |
| 60 | Hyperactive renin-angiotensin system (HP:0000841) | 2.84917446 |
| 61 | Emphysema (HP:0002097) | 2.84298607 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.83825304 |
| 63 | Gingivitis (HP:0000230) | 2.83599740 |
| 64 | Nephritis (HP:0000123) | 2.83456723 |
| 65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.83361090 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.75252521 |
| 67 | Hemoptysis (HP:0002105) | 2.74920231 |
| 68 | Abnormality of male internal genitalia (HP:0000022) | 2.73610246 |
| 69 | Chronic otitis media (HP:0000389) | 2.72775300 |
| 70 | Recurrent abscess formation (HP:0002722) | 2.72314749 |
| 71 | Pulmonary embolism (HP:0002204) | 2.69374980 |
| 72 | Eosinophilia (HP:0001880) | 2.69362152 |
| 73 | Chest pain (HP:0100749) | 2.68332817 |
| 74 | Alopecia of scalp (HP:0002293) | 2.66427699 |
| 75 | Abnormality of T cell physiology (HP:0011840) | 2.64220786 |
| 76 | Chronic diarrhea (HP:0002028) | 2.61165110 |
| 77 | Mitral stenosis (HP:0001718) | 2.58757661 |
| 78 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.53546948 |
| 79 | Villous atrophy (HP:0011473) | 2.53546948 |
| 80 | Abnormality of the nasal mucosa (HP:0000433) | 2.50945273 |
| 81 | Keratoconjunctivitis (HP:0001096) | 2.50356444 |
| 82 | Hypoproteinemia (HP:0003075) | 2.49377852 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.48296845 |
| 84 | Eczematoid dermatitis (HP:0000976) | 2.47704761 |
| 85 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.44003343 |
| 86 | Ureteral stenosis (HP:0000071) | 2.43297985 |
| 87 | Lymphoma (HP:0002665) | 2.42312534 |
| 88 | Neutropenia (HP:0001875) | 2.38753558 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.38276449 |
| 90 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.37926695 |
| 91 | Osteolytic defects of the hand bones (HP:0009699) | 2.37926695 |
| 92 | Periodontitis (HP:0000704) | 2.37022362 |
| 93 | Arterial thrombosis (HP:0004420) | 2.35454317 |
| 94 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.33863248 |
| 95 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31243263 |
| 96 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31243263 |
| 97 | Recurrent bacterial skin infections (HP:0005406) | 2.30812092 |
| 98 | Neoplasm of the lung (HP:0100526) | 2.27706723 |
| 99 | Right ventricular cardiomyopathy (HP:0011663) | 2.27271256 |
| 100 | Abnormality of eosinophils (HP:0001879) | 2.25368522 |
| 101 | Fragile skin (HP:0001030) | 2.23287796 |
| 102 | Thrombophlebitis (HP:0004418) | 2.23206338 |
| 103 | Granulocytopenia (HP:0001913) | 2.22003761 |
| 104 | Skin ulcer (HP:0200042) | 2.19611767 |
| 105 | Stomatitis (HP:0010280) | 2.18316733 |
| 106 | Viral hepatitis (HP:0006562) | 2.17605989 |
| 107 | Ankyloglossia (HP:0010296) | 2.17011461 |
| 108 | Abnormality of the pleura (HP:0002103) | 2.16319735 |
| 109 | Pustule (HP:0200039) | 2.15669752 |
| 110 | Ureteral obstruction (HP:0006000) | 2.14582601 |
| 111 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.13405942 |
| 112 | Encephalitis (HP:0002383) | 2.13087107 |
| 113 | Hypermelanotic macule (HP:0001034) | 2.12211170 |
| 114 | Increased IgM level (HP:0003496) | 2.09336357 |
| 115 | Metaphyseal cupping (HP:0003021) | 2.08197283 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 2.06121336 |
| 117 | Duplicated collecting system (HP:0000081) | 2.05476305 |
| 118 | Purpura (HP:0000979) | 2.05455955 |
| 119 | Thrombocytosis (HP:0001894) | 2.04674087 |
| 120 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.03895845 |
| 121 | Vertebral arch anomaly (HP:0008438) | 2.01179516 |
| 122 | Atrophic scars (HP:0001075) | 1.98526980 |
| 123 | Abnormality of oral frenula (HP:0000190) | 1.96559848 |
| 124 | Aortic dissection (HP:0002647) | 1.95467236 |
| 125 | Decreased circulating renin level (HP:0003351) | 1.94838479 |
| 126 | Neoplasm of the respiratory system (HP:0100606) | 1.93970758 |
| 127 | Peritonitis (HP:0002586) | 1.93257028 |
| 128 | Polyneuropathy (HP:0001271) | 1.92514660 |
| 129 | Entropion (HP:0000621) | 1.91863157 |
| 130 | Seborrheic dermatitis (HP:0001051) | 1.90731520 |
| 131 | Gingival bleeding (HP:0000225) | 1.89866991 |
| 132 | Limb hypertonia (HP:0002509) | 1.88730353 |
| 133 | Leukocytosis (HP:0001974) | 1.86497923 |
| 134 | Recurrent skin infections (HP:0001581) | 1.86239852 |
| 135 | Pancreatitis (HP:0001733) | 1.85848025 |
| 136 | Bronchiectasis (HP:0002110) | 1.81485284 |
| 137 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.80121375 |
| 138 | Anorexia (HP:0002039) | 1.78928163 |
| 139 | Erythroderma (HP:0001019) | 1.77790796 |
| 140 | Hypokinesia (HP:0002375) | 1.77181136 |
| 141 | Pulmonary fibrosis (HP:0002206) | 1.76141918 |
| 142 | Glomerulopathy (HP:0100820) | 1.74029026 |
| 143 | Arthralgia (HP:0002829) | 1.72906925 |
| 144 | Autoimmune thrombocytopenia (HP:0001973) | 1.72812669 |
| 145 | Subacute progressive viral hepatitis (HP:0006572) | 1.69913804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.85338501 |
| 2 | ERN1 | 5.21651546 |
| 3 | MAP4K1 | 4.39706429 |
| 4 | MAP3K10 | 3.60083068 |
| 5 | PRPF4B | 3.27902446 |
| 6 | GRK6 | 3.21787946 |
| 7 | MST1R | 3.08463865 |
| 8 | SYK | 2.45461068 |
| 9 | TAOK3 | 2.33505677 |
| 10 | EPHA3 | 2.32965305 |
| 11 | BUB1 | 2.25061403 |
| 12 | CSF1R | 2.15058123 |
| 13 | MAP3K14 | 2.06883364 |
| 14 | EIF2AK3 | 1.88470284 |
| 15 | CDC42BPA | 1.88396790 |
| 16 | EPHB1 | 1.88276363 |
| 17 | RIPK1 | 1.83457228 |
| 18 | BTK | 1.81034888 |
| 19 | MAP3K13 | 1.71185412 |
| 20 | EEF2K | 1.68809343 |
| 21 | RIPK4 | 1.68338128 |
| 22 | PIK3CA | 1.51118630 |
| 23 | FES | 1.50509226 |
| 24 | JAK3 | 1.49775232 |
| 25 | MST4 | 1.48510761 |
| 26 | LYN | 1.44608425 |
| 27 | WNK1 | 1.38068142 |
| 28 | PDGFRA | 1.35768862 |
| 29 | STK10 | 1.35316356 |
| 30 | PKN2 | 1.34120875 |
| 31 | JAK1 | 1.33480909 |
| 32 | ITK | 1.32629485 |
| 33 | TYK2 | 1.31191779 |
| 34 | KIT | 1.28856126 |
| 35 | NEK2 | 1.28051288 |
| 36 | TBK1 | 1.27246343 |
| 37 | CCNB1 | 1.26566245 |
| 38 | SIK2 | 1.22652918 |
| 39 | NME2 | 1.19673399 |
| 40 | STK24 | 1.15136707 |
| 41 | MAP3K1 | 1.14849429 |
| 42 | HCK | 1.13915807 |
| 43 | MARK3 | 1.13398274 |
| 44 | LCK | 1.12290940 |
| 45 | TEC | 1.11464606 |
| 46 | MAPK4 | 1.11408061 |
| 47 | LRRK2 | 1.09998753 |
| 48 | YES1 | 1.08606705 |
| 49 | IRAK4 | 1.08076095 |
| 50 | BMPR2 | 1.03162090 |
| 51 | IRAK1 | 0.99718204 |
| 52 | DDR2 | 0.97871801 |
| 53 | MET | 0.94779224 |
| 54 | BLK | 0.93019809 |
| 55 | FER | 0.91446070 |
| 56 | STK4 | 0.91064826 |
| 57 | CDK6 | 0.90797735 |
| 58 | FGR | 0.87828273 |
| 59 | PRKCQ | 0.87604081 |
| 60 | EIF2AK1 | 0.87207766 |
| 61 | TESK2 | 0.84067049 |
| 62 | PIM1 | 0.82762918 |
| 63 | TAOK1 | 0.82422873 |
| 64 | CDK4 | 0.81477313 |
| 65 | JAK2 | 0.81205185 |
| 66 | FGFR3 | 0.80216619 |
| 67 | CHUK | 0.80183295 |
| 68 | IKBKE | 0.79740942 |
| 69 | IKBKB | 0.79567359 |
| 70 | NLK | 0.79267465 |
| 71 | SMG1 | 0.79164880 |
| 72 | IRAK3 | 0.78652361 |
| 73 | MAP3K3 | 0.78506489 |
| 74 | CSK | 0.78296678 |
| 75 | FLT3 | 0.78183975 |
| 76 | PDK1 | 0.76034641 |
| 77 | SRPK1 | 0.75071792 |
| 78 | TRIB3 | 0.74727760 |
| 79 | TAOK2 | 0.74356675 |
| 80 | EPHA2 | 0.69273274 |
| 81 | PRKG2 | 0.68434568 |
| 82 | KSR2 | 0.66727788 |
| 83 | NEK9 | 0.66326930 |
| 84 | RPS6KB2 | 0.66244788 |
| 85 | MAP2K3 | 0.64977584 |
| 86 | ZAP70 | 0.64806684 |
| 87 | TNK2 | 0.64677752 |
| 88 | MAP3K6 | 0.64234408 |
| 89 | SCYL2 | 0.62715188 |
| 90 | TLK1 | 0.62463356 |
| 91 | HIPK2 | 0.61673659 |
| 92 | MATK | 0.61612163 |
| 93 | NUAK1 | 0.61517832 |
| 94 | RET | 0.61403570 |
| 95 | DMPK | 0.59984941 |
| 96 | PTK6 | 0.59147319 |
| 97 | PDGFRB | 0.58441894 |
| 98 | FYN | 0.57914739 |
| 99 | MAPK11 | 0.55759705 |
| 100 | CLK1 | 0.55004137 |
| 101 | SIK3 | 0.54152520 |
| 102 | BRSK2 | 0.53904121 |
| 103 | PAK4 | 0.51218269 |
| 104 | PKN1 | 0.51195825 |
| 105 | MAPK7 | 0.50633421 |
| 106 | TGFBR1 | 0.49936815 |
| 107 | CSNK1A1L | 0.49221140 |
| 108 | TGFBR2 | 0.48031948 |
| 109 | MAP3K8 | 0.47934923 |
| 110 | CSNK1G3 | 0.47685067 |
| 111 | PRKCD | 0.47681297 |
| 112 | MAPK12 | 0.47565007 |
| 113 | RPS6KB1 | 0.47157655 |
| 114 | MYLK | 0.47153720 |
| 115 | BRSK1 | 0.47153459 |
| 116 | CDK12 | 0.45748675 |
| 117 | EPHB2 | 0.44969980 |
| 118 | PLK3 | 0.44505395 |
| 119 | CHEK2 | 0.44473150 |
| 120 | FGFR4 | 0.44334037 |
| 121 | ACVR1B | 0.43990859 |
| 122 | GRK5 | 0.43824055 |
| 123 | ABL1 | 0.42936673 |
| 124 | IGF1R | 0.41537088 |
| 125 | KDR | 0.40260913 |
| 126 | ALK | 0.40059929 |
| 127 | UHMK1 | 0.39869605 |
| 128 | ATR | 0.37021903 |
| 129 | CSNK1G1 | 0.36880980 |
| 130 | PIK3CG | 0.36520881 |
| 131 | MAP2K2 | 0.36368845 |
| 132 | SIK1 | 0.36237181 |
| 133 | PRKCH | 0.35788218 |
| 134 | WEE1 | 0.33711082 |
| 135 | OXSR1 | 0.33200338 |
| 136 | EGFR | 0.32871388 |
| 137 | PDPK1 | 0.32667537 |
| 138 | FRK | 0.32204356 |
| 139 | PRKD2 | 0.31897134 |
| 140 | MAP3K2 | 0.31746952 |
| 141 | LMTK2 | 0.31633455 |
| 142 | MAPKAPK2 | 0.30282698 |
| 143 | GRK1 | 0.29961717 |
| 144 | MELK | 0.29952091 |
| 145 | INSR | 0.29691673 |
| 146 | CDK19 | 0.28445509 |
| 147 | AURKB | 0.28211228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.89300042 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 5.15435311 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.27427432 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.86348410 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.52738926 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.32897189 |
| 7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.30845670 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.05935716 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64323695 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.48988372 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.12303500 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11272423 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.08912893 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94689714 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.84254875 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76239391 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.65752433 |
| 18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42760494 |
| 19 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42149816 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.40856792 |
| 21 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.40712346 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.38528349 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.34931697 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30391331 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29937703 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.25570849 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.24924770 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23774863 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22947207 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.22738088 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.22334978 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20207699 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19028898 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.14430615 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.14022851 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.08808466 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.07463585 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.07335048 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03165404 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.01604991 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99284767 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 0.98682322 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98313711 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97599129 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 0.96497500 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95945865 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.95163210 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93679194 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.92794717 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90149133 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89203625 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85166313 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84993355 |
| 54 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83639047 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83042020 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82785425 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81685097 |
| 58 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.81088753 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79993997 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78940560 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.76771499 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.74217168 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71160840 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70586701 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69867403 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 0.69572589 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69335798 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68255425 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68016114 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.67603154 |
| 71 | Ribosome_Homo sapiens_hsa03010 | 0.65718790 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.65560336 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62685056 |
| 74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58995059 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58479129 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.56425305 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.54453670 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54167205 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53036797 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51175639 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50813592 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48815166 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48153605 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46861986 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46465754 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45751869 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45442789 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42339688 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42304741 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.40681183 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39090650 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.37208372 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36926329 |
| 94 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36611959 |
| 95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36385201 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34402436 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34330567 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33500764 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.33166682 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32307131 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30244017 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.29926845 |
| 103 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.29243280 |
| 104 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29138273 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28735402 |
| 106 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.28726084 |
| 107 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28646906 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.27761380 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.27706891 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27453029 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27357286 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26300395 |
| 113 | Cell cycle_Homo sapiens_hsa04110 | 0.25866565 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.25434927 |
| 115 | Spliceosome_Homo sapiens_hsa03040 | 0.24564421 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24495640 |
| 117 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.23785626 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.23340352 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23048664 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19845377 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18158523 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.16747150 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.15310313 |
| 124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14089924 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13454198 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.12795098 |
| 127 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.11710199 |
| 128 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.10846653 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.10770883 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.09635186 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.09327676 |
| 132 | Lysine degradation_Homo sapiens_hsa00310 | 0.08780979 |
| 133 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.08360130 |

